145 related articles for article (PubMed ID: 34411581)
1. Evaluation of chronic toxicity of cyclocreatine in beagle dogs after oral gavage administration for up to 23 weeks.
Wallery JJ; Kale VP; Novak J; Gibbs S; Do MT; McKew JC; Terse PS
Toxicol Appl Pharmacol; 2021 Nov; 430():115680. PubMed ID: 34411581
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks.
Kale VP; Wallery J; Novak J; Gibbs S; Bourdi M; Do MT; McKew JC; Terse PS
Regul Toxicol Pharmacol; 2020 Nov; 117():104750. PubMed ID: 32745584
[TBL] [Abstract][Full Text] [Related]
3. NTP technical report on the toxicology and carcinogenesis studies of Elmiron (Cas No. 37319-17-8) in F344/N rats and B6C3F1 mice (Gavage Studies).
National Toxicology Program, Public Health Services, National Institutes of Health, US Department of Health and Human Services,
Natl Toxicol Program Tech Rep Ser; 2004 May; (512):7-289. PubMed ID: 15213766
[TBL] [Abstract][Full Text] [Related]
4. Use of an animal model of disease for toxicology enables identification of a juvenile no observed adverse effect level for cyclocreatine in creatine transporter deficiency.
Do MT; Cavagnaro J; Butt M; Terse PS; McKew JC
Regul Toxicol Pharmacol; 2021 Jul; 123():104939. PubMed ID: 33961952
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
7. 28-day repeated dose toxicity and toxicokinetics study on new melatonergic antidepressant GW117 in beagle dogs.
Gao M; Chen K; Gu W; Liu X; Liu T; Ying Y; Cao C; Zhang Y; Zhang D; Yang G
J Appl Toxicol; 2023 Apr; 43(4):577-588. PubMed ID: 36268681
[TBL] [Abstract][Full Text] [Related]
8. Myocardial protection during ischemia by prior feeding with the creatine analog: cyclocreatine.
Jacobstein MD; Gerken TA; Bhat AM; Carlier PG
J Am Coll Cardiol; 1989 Jul; 14(1):246-51. PubMed ID: 2738267
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
10. Oral repeated-dose toxicity studies of BIA 10-2474 in beagle dogs.
Hardisty JF; Harris SB; Hayes WA; Weber K
Regul Toxicol Pharmacol; 2020 Mar; 111():104555. PubMed ID: 31874201
[TBL] [Abstract][Full Text] [Related]
11. Cyclocreatine in cancer chemotherapy.
Teicher BA; Menon K; Northey D; Liu J; Kufe DW; Kaddurah-Daouk R
Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923
[TBL] [Abstract][Full Text] [Related]
12. Subchronic oral toxicity and metabolite profiling of the p53 stabilizing agent, CP-31398, in rats and dogs.
Johnson WD; Muzzio M; Detrisac CJ; Kapetanovic IM; Kopelovich L; McCormick DL
Toxicology; 2011 Nov; 289(2-3):141-50. PubMed ID: 21864638
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873
[TBL] [Abstract][Full Text] [Related]
14. Toxicological evaluation of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine (VNP40101M), a novel alkylating agent with potential antitumor activity, with intravenous administration in rats and dogs.
Lee KC; Almassian B; Noveroske J
Int J Toxicol; 2002; 21(1):23-38. PubMed ID: 11936896
[TBL] [Abstract][Full Text] [Related]
15. Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs.
Mao Y; Zhang X; Li L; Yuan B; Lu G
Regul Toxicol Pharmacol; 2008 Feb; 50(1):75-86. PubMed ID: 18039554
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of pulegone (CAS No. 89-82-7) in F344/N rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2011 Aug; (563):1-201. PubMed ID: 21921962
[TBL] [Abstract][Full Text] [Related]
17. NTP toxicology and carcinogenesis studies of 5-(Hydroxymethyl)-2-furfural (CAS No. 67-47-0) in F344/N rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2010 Jun; (554):7-13, 15-9, 21-31 passim. PubMed ID: 20725154
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of cardiac function by cyclocreatine in models of cardiopulmonary bypass.
Houser SL; Elkerm AF; Wei Z; Doyle K; Houser D; Liu XK; Tyles E; Kaddurah-Daouk R; Elgebaly SA
J Mol Cell Cardiol; 1995 Apr; 27(4):1065-73. PubMed ID: 7563103
[TBL] [Abstract][Full Text] [Related]
19. Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells.
Bourdi M; Rudloff U; Patnaik S; Marugan J; Terse PS
Regul Toxicol Pharmacol; 2020 Oct; 116():104716. PubMed ID: 32619635
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
